Phase I study of TP300 in patients with advanced solid tumors with pharmacokinetic, pharmacogenetic and pharmacodynamic analyses.
BMC cancer 2012 12 (1): 536.
Anthoney D Alan, Naik Jay, Macpherson Iain R J, Crawford Donna, Hartley John M, Hartley Janet A, Saito Tomohisa, Abe Masaichi, Jones Keith, Miwa Masanori, Twelves Christopher, Evans T R
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 29, 2019
- Content source: